Stocks and Investing
Stocks and Investing
Fri, March 8, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, March 7, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Andrew Fein Reiterated (TCRX) at Strong Buy and Held Target at $15 on, Mar 7th, 2024
Andrew Fein of HC Wainwright & Co., Reiterated "TScan Therapeutics, Inc." (TCRX) at Strong Buy and Held Target at $15 on, Mar 7th, 2024.
Andrew has made no other calls on TCRX in the last 4 months.
There is 1 other peer that has a rating on TCRX. Out of the 1 peers that are also analyzing TCRX, 0 agree with Andrew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Andrew
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $9 on, Thursday, February 1st, 2024
Contributing Sources